netarsudil mesylate

netarsudil mesylate (RHOPRESSA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

RHOPRESSA is a marketed brand name for netarsudil mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

netarsudil mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.